Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-07
1998-04-14
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 16, 514 18, 514 19, 530303, 530307, 530312, 530324, 530331, 530328, A61K 3800, A61K 3828, C07K 500, C07K 700
Patent
active
057391068
ABSTRACT:
Compositions and methods for reducing food intake, suppressing appetite and controlling body weight are provided. Such compositions may include an amylin agonist and a CCK agonist or a hybrid peptide.
REFERENCES:
patent: 5264372 (1993-11-01), Beaumont et al.
patent: 5321008 (1994-06-01), Beaumont et al.
patent: 5367052 (1994-11-01), Cooper et al.
patent: 5376638 (1994-12-01), Young et al.
patent: 5580953 (1996-12-01), Albrecht et al.
U.S. application Ser. No. 08/447,080, filed May 30, 1995.
Arano, et al., Bioconj. Chem. 2:71-76 (1991).
Balasubramaniam, et al., Peptides 12:919-924 (1991).
Barrett-Connor, Am. J. Epidemiol. 113:276-284 (1981).
Beaumont, et al., Mol. Pharmacol. 44:493-497 (1993).
Brain, et al., Eur. J. Pharmacol. 183:2221 (1990).
Bray, Dis. Mon. 26:1-85 (1979).
Butler, et al., Am. J. Epidemiol. 16:971-980 (1982).
Chance, et al., Brain Res. 539:352-354 (1991).
Chantry, et al., Biochem. J. 277:139-143 (1991).
Chiang, et al., Circulation 39:403-421 (1969).
Cooper, et al., Proc. Nat Acad. Sci. 85:7763-7766 (1988).
Cooper, et al., Proc. Natl Acad. Sci., USA 84:8628-8632 (1987).
Cooper, et al., Biochem. Biophys. Acta 1014:247-258 (1989).
Cox, Behav. Brain Res. 38:35-44 (1990).
Crawley and Corwin, Peptides 15: 731-755 (1994).
Deems, et al., Biochem. Biophys. Res. Commun. 181:116-120 (1991).
Dulawa, et al., Peptides 15:913-918 (1994).
Follett, et al., Clinical Research 39:39A (1991).
Frontoni, et al., Diabetes 40:568-573 (1991).
Galeazza, et al., Peptides 12:585-591 (1991).
Gardiner, et al., Diabetes 40:948-951 (1991).
Gedulin, et al., Biochem. Biophys. Res. Commun. 180:782-789 (1991).
Gill, et al., Life Sciences 48:703-710 (1991).
Gomez-Foix, et al., Biochem. J. 276:607-610 (1991).
Hartter, et al., Diabetologia 34:52-54 (1991).
Hinton, et al., Brain Res. Bull. 17:615-619 (1986).
Huang, et al., Hypertension 19:I101-I109 (1991).
Jarrett, et al., Int. J. Epidemiol. 7:15-24 (1978).
Kanatsuka, et al., FEBS Letts. 259:199-201 (1989).
King, et al., Cancer Research 54:6176-6185 (1994).
Koda, et al., The Lancet 339:1179-1180 (1992).
Kolata, Science 227:1019-1020 (1985).
Koopmans, et al., Diabetologia 34:218-224 (1991).
Leighton, et al., Nature 335:632-635 (1988).
LeSauter and Geary, Am. J. Physiol. 253:R719-725 (1987).
Lieverse, et al., Ann. N.Y. Acad. Sci. 713:268-272 (1994).
Lupien and Young, Diabetes Nutrition and Metabolism--Clinical and Experimental 6:13-18 (1993).
Lutz, et al., Physiology & Behavior 55:891-895 (1994).
Medalie, et al., Arch. Int. Med. 135:811-817 (1975).
Modan, et al., J. Clin. Invest. 75:809-817 (1985).
Molina, et al., Diabetes 39:260-265 (1990).
Moore, et al., Biochem. Biophys. Res. Commun. 179:1-9 (1991).
Morley, et al., Pharmacol. Biochem. Behav. 44:577-580 (1993).
Morley and Flood, Peptides 12:865-869 (1991).
Morley, et al., Am. J. Physiol. 267:R178-R184 (1994).
Moyses and Kolterman, Drugs of the Future (May 1995).
Ogawa, et al., J. Clin. Invest. 85:973-976 (1990).
Pittner, et al., J. Cell. Biochem. 55S:19-28 (1994).
Reidelberger, J. Nutr. 124(8) 1327S-1333S (1994).
Roden, et al., Diabetologia 35:116-120 (1992).
Sanke, et al., Diabetologia 34:129-132 (1991).
Sims, Hypertension 4(3):111-43-111-49 (1982).
Smith and Gibbs, Annals N.Y. Acad. Sci. 713:236-241 (1994).
Stephens, et al., Diabetes 40:395-400 (1991).
Wang, et al., FEBS Letts. 219:195-198 (1991).
Weber, et al., Bioconj. Chem. 1:431-437 (1990).
Young, et al., Am. J. Physiol. 259:E457-E461 (1990).
Young, et al., FEBS Letts. 281:149-151 (1991).
Young, et al., J. Cell. Biochem. 55S:12-18 (1994).
Young, et al., Am. J. Physiol. 263:E274-E281 (1992).
Young, et al., Diabetologia 38:642-648 (1995).
Zhu, et al., Biochem. Biophys. Res. Commun. 177:771-776 (1991).
Zierath, et al., Diabetologia 35:26-31 (1992).
Zimmett, Diabetologia 22:399-411 (1982).
Azria, Calcitonins--Physiological and Pharmacological Aspects, pp. 1-34, Springer-Verlag (1989).
Harrison's Principles of Internal Medicine, 12th Ed., McGraw Hill, Inc. (1991) p. 411.
Quadri, et al., "Optimization of biodistribution by introducing different chemical linkages betwen antibody and an indium-111 chelate," Cancer Imaging with Radiolabeled Antibodies, Goldenberg (ed.), (1990), pp. 201-213.
Walsh, "Gastrointestinal Hormones," Physiology of the Gastrointestinal Tract 3d Ed., Raven Press, (1994) New York.
West, Epidemiology of Diabetes and its Vascular Lesions, Elsevier/North Holland, New York, pp. 191-284, 351-389 (1978).
Beeley Nigel Robert Arnold
Prickett Kathryn S.
Rink Timothy J.
Young Andrew A.
Harle Jennifer
Tsang Cecilia J.
LandOfFree
Appetite regulating compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Appetite regulating compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Appetite regulating compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-634577